Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Siga Technologies Inc. (SIGA) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Drug Manufacturers - Specialty & Generic
$3.56
+0.14 (4.09%)Did SIGA Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if SIGA Technologies is one of their latest high-conviction picks.
SIGA has shown a year-to-date change of -41.7% and a 1-year change of -47.5%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for SIGA. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for SIGA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 6, 2012 | Wedbush | Outperform | Maintains | $7.50 |
The following stocks are similar to SIGA Technologies based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Siga Technologies Inc. has a market capitalization of $245.30M with a P/E ratio of 12.2x. The company generates $93.78M in trailing twelve-month revenue with a 21.6% profit margin.
Revenue growth is -11.3% quarter-over-quarter, while maintaining an operating margin of -85.2% and return on equity of +11.0%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops therapeutics for health security threats.
Siga Technologies generates revenue by developing and commercializing antiviral therapeutics for biological threats, particularly through government and military contracts focused on biodefense. Their flagship product, TPOXX, is a smallpox antiviral that plays a critical role in addressing public health emergencies.
The company is headquartered in the United States and works closely with government agencies to ensure the strategic stockpiling of medical countermeasures. Its contributions are vital for national security and emergency preparedness against biological warfare and contagious disease outbreaks.
Healthcare
Drug Manufacturers - Specialty & Generic
49
Dr. Diem Nguyen M.B.A., Ph.D.
United States
1997
Siga Technologies (NASDAQ: SIGA) reported a first-quarter loss due to minimal product deliveries, but anticipates increased sales in Q2 from an international order and U.S. Stockpile deliveries.
Siga Technologies' projected increase in deliveries could signal revenue growth, impacting stock performance and investor sentiment positively if expectations are met.
SIGA Technologies, Inc. reported its Q1 2026 earnings, detailing financial performance and updates. For specific figures and insights, refer to the full earnings call transcript.
The Q1 2026 earnings call provides insights into SIGA's financial performance and future outlook, influencing stock valuation and investor sentiment.
SIGA Technologies, Inc. (Nasdaq: SIGA) reported its financial results for Q1 2026, ending March 31. Further details on performance were not included in the excerpt.
SIGA's financial results can indicate its market performance and growth potential, impacting stock value and investor sentiment in the pharmaceutical sector.
SIGA Technologies will hold a webcast and conference call on May 7, 2026, at 4:30 PM ET for a business update, featuring CEO Diem Nguyen and CFO Daniel Luckshire.
The upcoming webcast and conference call by SIGA Technologies may reveal critical business developments, financial performance, or strategic plans that could impact stock performance and investor sentiment.
SIGA Technologies announced a special cash dividend of $0.60 per share, payable on April 23, 2026, to shareholders of record by April 7, 2026. This matches last year's special dividend amount.
A special cash dividend signals financial strength and returning value to shareholders, which can enhance investor confidence and potentially boost stock price.
Siga's board declared a special cash dividend of $0.60 per share, matching the amount from the special dividend announced in April.
Siga's $0.60 special cash dividend signals strong cash reserves and consistent performance, potentially boosting shareholder confidence and stock attractiveness.
Analyst forecasts for Siga Technologies Inc. (SIGA) are not currently available. The stock is trading at $3.56.
Analyst ratings for SIGA are not currently available. The stock is currently trading at $3.56. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for SIGA are not currently available. The stock is trading at $3.56.
Siga Technologies generates revenue by developing and commercializing antiviral therapeutics for biological threats, particularly through government and military contracts focused on biodefense. Their flagship product, TPOXX, is a smallpox antiviral that plays a critical role in addressing public health emergencies.
Price targets from Wall Street analysts for SIGA are not currently available. The stock is trading at $3.56.
Price targets from Wall Street analysts for SIGA are not currently available. The stock is trading at $3.56.
Analyst ratings for SIGA are not currently available. The stock is trading at $3.56.
Stock price projections, including those for Siga Technologies Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.